BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37307001)

  • 21. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
    JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
    Guo Y; Duan H; Cheng J; Zhang Y
    BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia.
    Li Z; Li X; Lin M; Qiu S; Wang L; Lai L; Luo X; Mo Z; Dong G; Lyu G; Li S
    Int J Hyperthermia; 2022; 39(1):1335-1343. PubMed ID: 36257919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder: A Randomized Clinical Trial.
    Landgren V; Malki K; Bottai M; Arver S; Rahm C
    JAMA Psychiatry; 2020 Sep; 77(9):897-905. PubMed ID: 32347899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial.
    Kim YW; Bae JM; Park YK; Yang HK; Yu W; Yook JH; Noh SH; Han M; Ryu KW; Sohn TS; Lee HJ; Kwon OK; Ryu SY; Lee JH; Kim S; Yoon HM; Eom BW; Choi MG; Kim BS; Jeong O; Suh YS; Yoo MW; Lee IS; Jung MR; An JY; Kim HI; Kim Y; Yang H; Nam BH;
    JAMA; 2017 May; 317(20):2097-2104. PubMed ID: 28535237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of symptomatic uterine adenomyosis with linzagolix, an oral gonadotrophin-releasing hormone antagonist: a pilot study.
    Donnez J; Donnez O; Brethous M; Bestel E; Garner E; Charpentier S; Humberstone A; Loumaye E
    Reprod Biomed Online; 2022 Jan; 44(1):200-203. PubMed ID: 34799277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.
    Fiscella K; Eisinger SH; Meldrum S; Feng C; Fisher SG; Guzick DS
    Obstet Gynecol; 2006 Dec; 108(6):1381-7. PubMed ID: 17138770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms.
    Pinzauti S; Lazzeri L; Tosti C; Centini G; Orlandini C; Luisi S; Zupi E; Exacoustos C; Petraglia F
    Ultrasound Obstet Gynecol; 2015 Dec; 46(6):730-6. PubMed ID: 25728241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea.
    Fox MC; Klipping C; Nguyen AM; Frenkl TL; Cruz SM; Wang Y; Korver T
    Contraception; 2019 Feb; 99(2):125-130. PubMed ID: 30439359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Electroacupuncture vs Sham Treatment on Change in Pain Severity Among Adults With Chronic Low Back Pain: A Randomized Clinical Trial.
    Kong JT; Puetz C; Tian L; Haynes I; Lee E; Stafford RS; Manber R; Mackey S
    JAMA Netw Open; 2020 Oct; 3(10):e2022787. PubMed ID: 33107921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder: A Randomized Clinical Trial.
    Hollander E; Jacob S; Jou R; McNamara N; Sikich L; Tobe R; Smith J; Sanders K; Squassante L; Murtagh L; Gleissl T; Wandel C; Veenstra-VanderWeele J
    JAMA Psychiatry; 2022 Aug; 79(8):760-769. PubMed ID: 35793101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial.
    Preskorn SH; Zeller S; Citrome L; Finman J; Goldberg JF; Fava M; Kakar R; De Vivo M; Yocca FD; Risinger R
    JAMA; 2022 Feb; 327(8):727-736. PubMed ID: 35191924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea.
    Osuga Y; Hayashi K; Kanda S
    Fertil Steril; 2020 Mar; 113(3):627-635.e1. PubMed ID: 32192595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
    Harada T; Ota I; Kitawaki J; Momoeda M; Maeda N; Akira S; Umeyama M; Sunaya T; Hirano K
    Contraception; 2022 Dec; 116():22-28. PubMed ID: 36057322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.